Here's what investors need to know after a rough two years for the airline industry.
Serious Investors Read Barron's
Make the smartest investment decisions with access to Barron's in-depth analysis and unrivaled market predictions — all conveniently accessed on eLesor.com. Learn More
Housing activity already looked set to slow, with or without the Federal Reserve’s recent moves. Higher prices could be giving buyers second though...
The apparel brand, which owns popular brands The North Face and Supreme, reported solid quarterly performance, disappoints investors by lowering it...
Paul McCartney’s notes for “Hey Jude” and two guitars are among the digital items on offer
The recently restituted 1913 painting will be offered for sale at Christie’s on March 1
Verizon Chairman and CEO Hans Vestberg made his first open-market stock purchase the day after the telecom giant reported fourth-quarter earnings.
Analysts generally praised Visa's results and outlook, giving the stock a lift.
Jefferies analyst Jonathan Petersen initiates coverage on shares of Marathon Digital with a Buy rating and a $51 price target.
Baillie Gifford's Gary Robinson is excited about the long-term prospects of the e-commerce software company.
New Street Research analyst Pierre Ferragu abandoned his Sell recommendation on Apple stock, setting a Hold rating and $165 target.
Tech stock investors nursing heavy losses so far this year may want to seek solace with a quick glance at the latest world’s richest person list.
China is watching the U.S. closely as it deals with Russia's threat to Ukraine, writes Brian P. Klein.
The University of Michigan consumer sentiment survey for January came in at 67.2, the lowest reading in more than a decade.
The biotech faces stiffer competition and growing pains as it makes a transition to a postpandemic vaccine market. Its big pile of cash should help.
Designers Gina and James de Givenchy combined two units to create a four-bedroom retreat on the Upper East Side
The Japanese auto maker has beaten German rival Volkswagen for the second year in a row.
Core inflation rose 4.9% on a yearly basis in December, according to data from the Bureau of Economic Analysis.
Analyst Bill Peterson upgraded his rating to Overweight from Neutral and lowered his price target to $20 from $26.
The stock held steady after the disappointing result, a sign that investors are focused on other issues, such as a plunge in the price of steel.
Biogen will be selling its stake in a biosimilars joint venture to partner Samsung Biologics for up to $2.3 billion.
Citi analyst Paul Lejuez said the grocer will face pressure as its costs rise and other retailers accept smaller margins in order to win market share.